WallStSmart

GE HealthCare Technologies Inc. (GEHC)vsLivaNova PLC (LIVN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

GE HealthCare Technologies Inc. generates 1364% more annual revenue ($20.98B vs $1.43B). GEHC leads profitability with a 9.1% profit margin vs 7.5%. LIVN appears more attractively valued with a PEG of 0.91. GEHC earns a higher WallStSmart Score of 57/100 (C).

GEHC

Buy

57

out of 100

Grade: C

Growth: 4.0Profit: 6.0Value: 5.7Quality: 4.5
Piotroski: 2/9Altman Z: 1.34

LIVN

Buy

52

out of 100

Grade: C-

Growth: 5.3Profit: 5.5Value: 6.0Quality: 5.5
Piotroski: 4/9Altman Z: 0.35
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for GEHC.

LIVNUndervalued (+6.1%)

Margin of Safety

+6.1%

Fair Value

$70.73

Current Price

$72.36

$1.63 discount

UndervaluedFair: $70.73Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GEHC2 strengths · Avg: 8.0/10
P/E RatioValuation
15.6x8/10

Attractively priced relative to earnings

Price/BookValuation
2.8x8/10

Reasonable price relative to book value

LIVN2 strengths · Avg: 8.5/10
Debt/EquityHealth
0.289/10

Conservative balance sheet, low leverage

PEG RatioValuation
0.918/10

Growing faster than its price suggests

Areas to Watch

GEHC4 concerns · Avg: 2.8/10
PEG RatioValuation
1.844/10

Expensive relative to growth rate

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

EPS GrowthGrowth
-30.9%2/10

Earnings declined 30.9%

Altman Z-ScoreHealth
1.342/10

Distress zone — elevated risk

LIVN4 concerns · Avg: 2.3/10
Profit MarginProfitability
7.5%3/10

7.5% margin — thin

P/E RatioValuation
40.5x2/10

Premium valuation, high expectations priced in

EPS GrowthGrowth
-45.6%2/10

Earnings declined 45.6%

Altman Z-ScoreHealth
0.352/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : GEHC

The strongest argument for GEHC centers on P/E Ratio, Price/Book.

Bull Case : LIVN

The strongest argument for LIVN centers on Debt/Equity, PEG Ratio. Revenue growth of 14.3% demonstrates continued momentum. PEG of 0.91 suggests the stock is reasonably priced for its growth.

Bear Case : GEHC

The primary concerns for GEHC are PEG Ratio, Piotroski F-Score, EPS Growth.

Bear Case : LIVN

The primary concerns for LIVN are Profit Margin, P/E Ratio, EPS Growth. A P/E of 40.5x leaves little room for execution misses.

Key Dynamics to Monitor

LIVN carries more volatility with a beta of 0.88 — expect wider price swings.

LIVN is growing revenue faster at 14.3% — sustainability is the question.

GEHC generates stronger free cash flow (112M), providing more financial flexibility.

Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

GEHC scores higher overall (57/100 vs 52/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

GE HealthCare Technologies Inc.

HEALTHCARE · MEDICAL DEVICES · USA

GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.

LivaNova PLC

HEALTHCARE · MEDICAL DEVICES · USA

LivaNova PLC, a medical device company, designs, develops, manufactures and sells therapeutic solutions globally. The company is headquartered in London, the United Kingdom.

Visit Website →

Want to dig deeper into these stocks?